Click for best price
Dermatophytosis Drugs Market Size, Share 2024
| Market size in 2023 |
US$ 7867.1 million
|
Forecast Market size by 2030 |
US$ 11440 million
|
| Growth Rate |
CAGR of 5.6% |
Number of Pages |
89 Pages |
This research report provides a comprehensive analysis of the Dermatophytosis Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Dermatophytosis Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Dermatophytosis Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Dermatophytosis Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Dermatophytosis Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Dermatophytosis Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Dermatophytosis Drugs market was valued at US$ 7867.1 million in 2023 and is projected to reach US$ 11440 million by 2030, at a CAGR of 5.6% during the forecast period.
The Dermatophytosis Treatment market refers to the pharmaceuticals and treatments used for the management and treatment of dermatophytosis, commonly known as ringworm. This market includes antifungal drugs, topical creams, and oral medications. The Dermatophytosis Treatment market has witnessed steady growth due to factors such as the increasing prevalence of dermatophytosis, improved diagnosis, and advancements in antifungal therapies. Geographically, the market is global, with regions experiencing varying degrees of dermatophytosis incidence.
Key Features:
The research report on the Dermatophytosis Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Dermatophytosis Drugs market.
Market Overview: The report provides a comprehensive overview of the Dermatophytosis Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Rx, OTC), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Dermatophytosis Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Dermatophytosis Drugs market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Dermatophytosis Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Dermatophytosis Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Dermatophytosis Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Dermatophytosis Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Dermatophytosis Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Dermatophytosis Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Dermatophytosis Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Market segment by Application
Global Dermatophytosis Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Novartis
- Pfizer
- Sanofi-Aventis
- Merck
- Enzon Pharmaceuticals
- Bayer
- Astellas Pharma
- GSK
- Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dermatophytosis Drugs, market overview.
Chapter 2: Global Dermatophytosis Drugs market size in revenue.
Chapter 3: Detailed analysis of Dermatophytosis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dermatophytosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Dermatophytosis Drugs Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 7867.1 million
|
| Forecast Market size by 2030 |
US$ 11440 million
|
| Growth Rate |
CAGR of 5.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
89 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dermatophytosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatophytosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatophytosis Drugs Overall Market Size
2.1 Global Dermatophytosis Drugs Market Size: 2023 VS 2030
2.2 Global Dermatophytosis Drugs Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dermatophytosis Drugs Players in Global Market
3.2 Top Global Dermatophytosis Drugs Companies Ranked by Revenue
3.3 Global Dermatophytosis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Dermatophytosis Drugs Companies in Global Market, by Revenue in 2023
3.5 Global Companies Dermatophytosis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatophytosis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Dermatophytosis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Dermatophytosis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Dermatophytosis Drugs Market Size Markets, 2023 & 2030
4.1.2 Rx
4.1.3 OTC
4.2 By Type - Global Dermatophytosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Dermatophytosis Drugs Revenue, 2019-2024
4.2.2 By Type - Global Dermatophytosis Drugs Revenue, 2025-2030
4.2.3 By Type - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatophytosis Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Dermatophytosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Dermatophytosis Drugs Revenue, 2019-2024
5.2.2 By Application - Global Dermatophytosis Drugs Revenue, 2025-2030
5.2.3 By Application - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Dermatophytosis Drugs Market Size, 2023 & 2030
6.2 By Region - Global Dermatophytosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Dermatophytosis Drugs Revenue, 2019-2024
6.2.2 By Region - Global Dermatophytosis Drugs Revenue, 2025-2030
6.2.3 By Region - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Dermatophytosis Drugs Revenue, 2019-2030
6.3.2 US Dermatophytosis Drugs Market Size, 2019-2030
6.3.3 Canada Dermatophytosis Drugs Market Size, 2019-2030
6.3.4 Mexico Dermatophytosis Drugs Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Dermatophytosis Drugs Revenue, 2019-2030
6.4.2 Germany Dermatophytosis Drugs Market Size, 2019-2030
6.4.3 France Dermatophytosis Drugs Market Size, 2019-2030
6.4.4 U.K. Dermatophytosis Drugs Market Size, 2019-2030
6.4.5 Italy Dermatophytosis Drugs Market Size, 2019-2030
6.4.6 Russia Dermatophytosis Drugs Market Size, 2019-2030
6.4.7 Nordic Countries Dermatophytosis Drugs Market Size, 2019-2030
6.4.8 Benelux Dermatophytosis Drugs Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Dermatophytosis Drugs Revenue, 2019-2030
6.5.2 China Dermatophytosis Drugs Market Size, 2019-2030
6.5.3 Japan Dermatophytosis Drugs Market Size, 2019-2030
6.5.4 South Korea Dermatophytosis Drugs Market Size, 2019-2030
6.5.5 Southeast Asia Dermatophytosis Drugs Market Size, 2019-2030
6.5.6 India Dermatophytosis Drugs Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Dermatophytosis Drugs Revenue, 2019-2030
6.6.2 Brazil Dermatophytosis Drugs Market Size, 2019-2030
6.6.3 Argentina Dermatophytosis Drugs Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dermatophytosis Drugs Revenue, 2019-2030
6.7.2 Turkey Dermatophytosis Drugs Market Size, 2019-2030
6.7.3 Israel Dermatophytosis Drugs Market Size, 2019-2030
6.7.4 Saudi Arabia Dermatophytosis Drugs Market Size, 2019-2030
6.7.5 UAE Dermatophytosis Drugs Market Size, 2019-2030
7 Dermatophytosis Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Dermatophytosis Drugs Major Product Offerings
7.1.4 Novartis Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Dermatophytosis Drugs Major Product Offerings
7.2.4 Pfizer Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis Dermatophytosis Drugs Major Product Offerings
7.3.4 Sanofi-Aventis Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Dermatophytosis Drugs Major Product Offerings
7.4.4 Merck Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.4.5 Merck Key News & Latest Developments
7.5 Enzon Pharmaceuticals
7.5.1 Enzon Pharmaceuticals Company Summary
7.5.2 Enzon Pharmaceuticals Business Overview
7.5.3 Enzon Pharmaceuticals Dermatophytosis Drugs Major Product Offerings
7.5.4 Enzon Pharmaceuticals Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.5.5 Enzon Pharmaceuticals Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Dermatophytosis Drugs Major Product Offerings
7.6.4 Bayer Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.6.5 Bayer Key News & Latest Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Company Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Dermatophytosis Drugs Major Product Offerings
7.7.4 Astellas Pharma Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.7.5 Astellas Pharma Key News & Latest Developments
7.8 GSK
7.8.1 GSK Company Summary
7.8.2 GSK Business Overview
7.8.3 GSK Dermatophytosis Drugs Major Product Offerings
7.8.4 GSK Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.8.5 GSK Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Dermatophytosis Drugs Major Product Offerings
7.9.4 Abbott Dermatophytosis Drugs Revenue in Global Market (2019-2024)
7.9.5 Abbott Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dermatophytosis Drugs Market Opportunities & Trends in Global Market
Table 2. Dermatophytosis Drugs Market Drivers in Global Market
Table 3. Dermatophytosis Drugs Market Restraints in Global Market
Table 4. Key Players of Dermatophytosis Drugs in Global Market
Table 5. Top Dermatophytosis Drugs Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Dermatophytosis Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Dermatophytosis Drugs Revenue Share by Companies, 2019-2024
Table 8. Global Companies Dermatophytosis Drugs Product Type
Table 9. List of Global Tier 1 Dermatophytosis Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatophytosis Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Dermatophytosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Dermatophytosis Drugs Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Dermatophytosis Drugs Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Dermatophytosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Dermatophytosis Drugs Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Dermatophytosis Drugs Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Dermatophytosis Drugs Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Dermatophytosis Drugs Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Dermatophytosis Drugs Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Dermatophytosis Drugs Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Dermatophytosis Drugs Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Dermatophytosis Drugs Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Dermatophytosis Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Dermatophytosis Drugs Revenue, (US$, Mn), 2025-2030
Table 30. Novartis Company Summary
Table 31. Novartis Dermatophytosis Drugs Product Offerings
Table 32. Novartis Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 33. Novartis Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Dermatophytosis Drugs Product Offerings
Table 36. Pfizer Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 37. Pfizer Key News & Latest Developments
Table 38. Sanofi-Aventis Company Summary
Table 39. Sanofi-Aventis Dermatophytosis Drugs Product Offerings
Table 40. Sanofi-Aventis Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 41. Sanofi-Aventis Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Dermatophytosis Drugs Product Offerings
Table 44. Merck Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 45. Merck Key News & Latest Developments
Table 46. Enzon Pharmaceuticals Company Summary
Table 47. Enzon Pharmaceuticals Dermatophytosis Drugs Product Offerings
Table 48. Enzon Pharmaceuticals Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 49. Enzon Pharmaceuticals Key News & Latest Developments
Table 50. Bayer Company Summary
Table 51. Bayer Dermatophytosis Drugs Product Offerings
Table 52. Bayer Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 53. Bayer Key News & Latest Developments
Table 54. Astellas Pharma Company Summary
Table 55. Astellas Pharma Dermatophytosis Drugs Product Offerings
Table 56. Astellas Pharma Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 57. Astellas Pharma Key News & Latest Developments
Table 58. GSK Company Summary
Table 59. GSK Dermatophytosis Drugs Product Offerings
Table 60. GSK Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 61. GSK Key News & Latest Developments
Table 62. Abbott Company Summary
Table 63. Abbott Dermatophytosis Drugs Product Offerings
Table 64. Abbott Dermatophytosis Drugs Revenue (US$, Mn) & (2019-2024)
Table 65. Abbott Key News & Latest Developments
List of Figures
Figure 1. Dermatophytosis Drugs Segment by Type in 2023
Figure 2. Dermatophytosis Drugs Segment by Application in 2023
Figure 3. Global Dermatophytosis Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Dermatophytosis Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Dermatophytosis Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermatophytosis Drugs Revenue in 2023
Figure 8. By Type - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 9. By Application - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 10. By Type - Global Dermatophytosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 12. By Application - Global Dermatophytosis Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 14. By Region - Global Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 15. By Country - North America Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 16. US Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 20. Germany Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 21. France Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 28. China Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. India Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 34. Brazil Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Dermatophytosis Drugs Revenue Market Share, 2019-2030
Figure 37. Turkey Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Dermatophytosis Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. Novartis Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Pfizer Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Sanofi-Aventis Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Merck Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Enzon Pharmaceuticals Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Bayer Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Astellas Pharma Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. GSK Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Abbott Dermatophytosis Drugs Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
